Indicators

Markets:

News

Latest News about LLY

Recent news which mentions LLY

...

26 27 28 29 30 31 32 33 Next >

What's Going With WeightWatchers Stock On Wednesday?

October 09, 2024

Why Eli Lilly Was Such a Healthy Stock Today

October 08, 2024

FDA Sparks Controversy With Sudden Removal Of Eli Lilly's Weight Loss Drug From Shortage List

October 08, 2024

(LLY) - Analyzing Eli Lilly's Short Interest

October 08, 2024

With Its GLP-1 Drugs No Longer in a Shortage, Is Now the Time to Buy Eli Lilly Stock?

October 08, 2024

Billion-Dollar News for Eli Lilly Stock Investors

October 07, 2024

10 Health Care Stocks Whale Activity In Today's Session

October 07, 2024

Regeneron Chief Flags Health Risks with Popular Weight-Loss Medications Like Ozempic, Says Company Targets Muscle Preservation For Its Obesity Drugs

October 07, 2024

2 Next-Gen Weight Loss Stocks That Are Worth Buying Right Now

October 07, 2024

Economist Justin Wolfers Points To Obesity Rate Decline As Ozempic And Wegovy Spur Historic Shift In Fight Against Obesity — Has US Reached A Turning Point?

October 06, 2024

Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades

October 05, 2024

Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages

October 04, 2024

Evaluating Eli Lilly Against Peers In Pharmaceuticals Industry

October 04, 2024

England's NHS Proposes Phased Rollout of Eli Lilly's Mounjaro, Considers Digital Services to Boost Access

October 04, 2024

Massive News for Hims & Hers Stock: The Truth About Today's Move

October 04, 2024

Texas Attorney General Sues Insulin Manufacturers and Pharmacy Benefit Managers Over Price-Fixing Conspiracy That Increased Prices by 1,000%

October 03, 2024

Cracking The Code: Understanding Analyst Reviews For Eli Lilly

October 03, 2024

Popular Weight Loss Drugs Like Ozempic Show Gap Between Clinical Trial Promises And Real-World Use, Study Reveals

October 03, 2024

Hims & Hers Health Stock Is Tumbling Thursday: Here's Why

October 03, 2024

This IPO Biotech Stock Could Be the Next Eli Lilly

October 03, 2024

Tandem Diabetes Insulin Pump Demand to Surge Despite Popular Demand Of Weight Loss Drugs, Bullish Analyst Says

October 02, 2024

Eli Lilly Commits $4.5B To New Facility, Banking On Mounjaro, Zepbound's Weight Loss Success Despite Short-Term Stock Challenges

October 02, 2024

Eli Lilly Invests $4.5B In New Medicine Foundry for Advanced Drug Manufacturing To Push US Pharma Boundaries

October 02, 2024

Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation

October 02, 2024

US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next

October 01, 2024

Eli Lilly's Options: A Look at What the Big Money is Thinking

October 01, 2024

Eli Lilly Eyes New Trials For Weight-Loss Drugs In Non-Obese Patients

October 01, 2024

Eli Lilly Aims To Expand Weight-Loss Drug Trials To Those At Risk, Not Just Overweight

October 01, 2024

Tradepulse Power Inflow Alert: Eli Lilly And Company Climbs 15 Points

September 30, 2024

Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate

September 30, 2024

...

26 27 28 29 30 31 32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.